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The diversity of the human antibody repertoire that is generated by V(D)J gene rearrange-
ment is extended by nine constant region genes that give antibodies their complex array
of effector functions. The application of high throughput sequencing to the study of V(D)J
gene rearrangements has led to significant recent advances in our understanding of the
antigen-binding repertoire. In contrast, our understanding of antibody function has changed
little, and mystery still surrounds the existence of four distinctive IgG subclasses. Recent
observations from murine models and from human studies ofVDJ somatic point mutations
suggest that the timing of emergence of cells from the germinal center may vary as a con-
sequence of class switching.This should lead to predictable differences in affinity between
isotypes.These differences, and varying abilities of the isotypes to fix complement and bind
FcRs, could help coordinate the humoral defenses over the time course of a response. We
therefore propose a Temporal Model of human IgE and IgG function in which early emer-
gence of IgE sensitizes sentinel mast cells while switching to IgG3 recruits FcγR-mediated
functions to the early response. IgG1 then emerges as the major effector of antigen clear-
ance, and subsequently IgG2 competes with IgG1 to produce immune complexes that
slow the inflammatory drive. Persisting antigen may finally stimulate high affinity IgG4
that outcompetes other isotypes and can terminate IgG1/FcγR-mediated activation via the
inhibitory FcγRIIB. In this way, IgG antibodies of different subclasses, at different con-
centrations and with sometimes opposing functions deliver cohesive, protective immune
function.
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differentiation
It is almost 50 years since the complete set of human antibody
isotypes was first described (1). For over 30 years, associations
have been explored between antibody classes and subclasses and
the response to particular pathogens (2). And for almost 30 years,
the relationships between cytokine production and antibody class
switching have been reported (3). Other rich sources of data that
have guided thinking about antibody isotype function have been
studies of immunodeficiencies, and the disease susceptibilities
with which they are associated (2, 4). Yet despite literally thousands
of such studies, and despite significant insights into the particulari-
ties of humoral immunity, no proposal has emerged that describes
how IgG antibody subclasses and other antibody isotypes work
together to provide protective immune functions. Here we pro-
pose a Temporal Model of human IgE and IgG antibody function,
in which there is a programed order to the emergence of the dif-
ferent IgG isotypes that reflects their genomic organization, with
switching and emergence being promoted or delayed at different
critical points through the action of cytokines. We suggest that
early in the germinal center reaction, IgM+ B cells switch to both
IgE and IgG3. Subsequently, IgG1 cells switch and emerge, fol-
lowed by IgG2-committed cells and finally, if antigen persists, by
IgG4-producing cells.
The Temporal Model has its genesis in recent observations of
IgE-switched cells in the mouse. These studies suggest that the
IgE response is not usually a late development arising from an
expanded clone of IgG-committed cells that develops through the
germinal center reaction. Rather, it has been shown that IgE class-
switched murine cells usually develop and exit the germinal center
reaction in the early phase of an immune response, and that they
rapidly differentiate into plasmablasts and plasma cells (5, 6). The
IgE-secreting plasma cells carry fewer somatic point mutations in
their rearranged V(D)J genes than IgG-secreting plasma cells (6),
and as a consequence their secreted antibodies are likely to be of
lower affinity.
There can be no doubt that IgE antibodies can also be produced
late in a response. Recent studies have confirmed the existence of
high affinity IgE, and of sequential switching to IgE within the
germinal centers of mice (7, 8). No attempt has been made here
to incorporate such late IgE into the model. The functions of
secretory IgA in mucosal secretions and of serum IgA are also not
considered, but the temporal model provides a coherent view of
the separate and joint activities of early IgE and the IgG subclasses.
Reports of early IgE in murine models provide a new perspec-
tive from which to consider some unusual features of human IgE
antibody gene sequences. We have shown that IgE-associated VDJ
genes from non-allergic individuals carry very few somatic point
mutations, and some IgE sequences carry no mutations at all (9).
In individuals with atopic dermatitis, unmutated sequences have
also been seen at relatively high frequency (10). In parasitized indi-
viduals, we have seen more highly mutated IgE sequences (11),
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but these sequences did not carry the pattern of mutations that
is considered the mutational signature of antigen selection within
the germinal center reaction (12). In some, though not all allergic
conditions, IgE sequences also lack this pattern of mutation (9, 10).
These studies can be understood if IgE class switching in
humans, as in the mouse, can occur early in the germinal cen-
ter reaction, and if such switching is rapidly followed by the
differentiation of IgE-switched cells into plasmablasts that leave
the germinal centers. Some continuing accumulation of somatic
point mutations might then take place, outside the germinal cen-
ters (13). This would give the mutations in those IgE sequences a
distinctly different pattern to that which is seen in IgG sequences
that emerge after multiple rounds of selection within the germinal
centers. Such selection typically leads to an accumulation of non-
synonymous (replacement) mutations in the complementarity
determining regions of the antibody genes (12).
In the context of invasion by pathogens, the production of early
IgE antibodies could allow widely dispersed mast cells to function
as sentinel cells (14), alerting the immune system to further incur-
sions or spread of the pathogens. Early IgE could function in this
way,despite its low affinity,because low affinity IgE has been shown
to function well on the surface of mast cells and basophils, if it is
directed against multiple epitopes on multivalent antigen (15, 16).
If class switching to IgE is rapidly followed by departure of
cells from the germinal center, the possibility that switching to
other isotypes may lead cells to follow other distinct developmen-
tal pathways cannot be ignored. We have therefore reconsidered
the functions of human IgG subclasses, and this has been done
in the light of our observations of somatic point mutations in
antibodies of different IgG subclasses. These observations provide
the broadest possible overview of humoral immunity. In an analy-
sis of almost 1,000 VDJ genes isolated from people living in an
area of endemic parasitism, a surprising and statistically signifi-
cant relationship was seen (11). IgG3-associated VDJ genes were
the least mutated VDJ gene sequences, and the mean number of
mutations seen in sequences associated with the other subclasses
corresponded to the position of each constant region gene within
the IGH gene locus. That is, IgG3< IgG1< IgG2< IgG4.
We hypothesize that differences in mean levels of mutation
arise because human B cells tend to follow a programed sequence
of class switching and departure from the germinal center reac-
tion. We propose that cells first switch from IgM to IgG3, then to
IgG1 and to IgG2 and finally to IgG4 following the genomic order-
ing of the constant region genes (Figure 1). This is not to deny the
reality of alternative switch pathways under the influence of par-
ticular cytokines (17). We propose that class switching is driven
by underlying probabilities, and switching is linked to emergence
from the germinal centers, leading to the generalizable sequence
of the Temporal Model. Through changes in probabilities associ-
ated with the expression of adhesion molecules and chemokine
receptors, switching could be closely followed by emergence, or
emergence could follow variable periods of proliferation, muta-
tion, and selection within the germinal centers. The model does
not attempt to resolve the timing of these events for each isotype.
The Temporal Model has parallels with models of division-
linked phenotypic change, including class switching, which sug-
gest that predictable order can emerge from stochastic processes
FIGURE 1 |TheTemporal Model of IgE/IgG class switching and
departure from the germinal center reaction. A programed sequence of
sequential switching is highlighted, though alternative switch pathways are
also indicated. The timing of switching events and the emergence of
different cell types from the germinal center reaction is suggested by the
extent of somatic point mutations carried by the cells. Many cytokines may
act to promote or delay class switching, as indicated.
because of differences in the underlying probabilities of differ-
ent outcomes (18, 19). It also is in line with modeling of the
dynamics of murine division-linked isotype switching that sug-
gested that the outcome of isotype switching, under the indirect
influence of cytokines, is biased toward switching to the immediate
downstream neighboring constant region gene (20).
Though a simple relationship between mutation numbers and
affinity in any sequence cannot be assumed, accumulating muta-
tions are generally considered to give rise to higher affinity anti-
bodies through selection within the germinal centers (21). Sequen-
tial departure of cells from the germinal centers should therefore
ensure that antibodies of different isotypes have predictable dif-
ferences in affinity. This in turn should ensure that despite the
different isotypes having some opposing actions, and despite the
changing relative concentrations of the different isotypes over time
(22), all antibodies at the time of their production should be able to
play their assigned roles. It should also ensure that inflammatory
processes are tightly controlled, through the temporal coordina-
tion of antibodies that have striking differences in their abilities to
bind FcγR and to fix complement.
There is good evidence that the IgG3 response occurs early, is
relatively transient and is of relatively low affinity (22, 23). This
is supported by our sequencing study, for IgG3-associated VDJ
genes had the fewest mutations of the IgG subclasses (mean 17.7
mutations), 31% of the sequences had less than 10 mutations and
7% of the sequences had no mutations at all (11). We propose that
class switching to IgG3, the first IgG subclass gene in the human
IGHC locus, first brings beneficial FcγR-mediated defenses into
play. The accumulation of some somatic point mutations dur-
ing the differentiation of IgG3-committed cells should ensure that
Frontiers in Immunology | B Cell Biology August 2013 | Volume 4 | Article 235 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collins and Jackson IgG subclasses and immune function
most IgG3 antibodies have experienced some affinity maturation,
and the specific physicochemical properties of IgG3 should mean
that the switch from IgM to IgG3 does not lead to a crippling loss
of binding avidity.
The principal “early” antibody, IgM, is able to provide use-
ful protection despite its low affinity, because of the multivalent
nature of secreted IgM, and because of its flexibility (24). The long
hinge region of IgG3 makes it the most flexible human IgG anti-
body (25). This should facilitate bivalent binding of high avidity
to repeated determinants on the surface of an invading pathogen.
As part of the early response, IgG3 antibodies would have to work
with IgM antibodies to efficiently trigger complement fixation and
engagement with FcγR-bearing cells. In fact, IgG3 has the highest
affinity of the IgG subclasses for C1q, the first component of the
classical complement cascade (26). It also has the highest affin-
ity for the FcγRIIIA and FcγRIIIB receptors, and its affinity for
FcγRIIA is second only to IgG1 (27).
The elongated hinge region makes IgG3 vulnerable to catab-
olism. IgG3 has a half-life of just 7 days (28) and shares a short
half-life with IgM (∼5 days) (29) and IgE (∼3 days) (30). This
rapid turnover of all three kinds of “early antibody” should facil-
itate the ever-increasing dominance, as a response progresses, of
higher affinity antibodies of other isotypes.
In our study of VDJ rearrangements, IgG1-associated sequences
were significantly more mutated than IgG3 sequences. The mean
mutation of VDJ utilizing the IgG1 gene, positioned immediately
downstream from IgG3, was 21.0 somatic point mutations, and
only 13% of sequences had fewer than 10 mutations (11). We
therefore suggest that IgG1-committed cells are the next cell type
to differentiate and depart the germinal centers. Although having
on average just three more mutations than IgG3 sequences, we sug-
gest that a number of days are likely to separate the average time
of departure of IgG3-committed cells and IgG1-committed cells.
It is generally accepted that mutations accumulate at the rate of
about one mutation per cell division (31), and centroblast division
time is thought to be around 7 h (32). It is likely, however, that as
increasing numbers of mutations accumulate, the probability that
further random mutations are beneficial is low (33). The speed
with which selected sequences accumulate mutations is therefore
likely to slow over the course of a response.
Class switching to IgG1 leads to the secretion of more highly
mutated, complement-fixing, FcγR-binding IgG antibodies that
often dominate the response to bacterial and viral invaders (34,
35). Certainly, IgG1 antibodies are the most abundant serum anti-
bodies (36). With their shorter hinge regions, IgG1 molecules lack
flexibility but with their higher affinity for antigen, even mono-
valent binding should be stable and effective. And with their high
affinity for C1q (26) and FcγRI, FcγRII, and FcγRIII (27), such
IgG1 antibodies would continue driving inflammatory processes
and antigen clearance.
Many studies report that IgG1 antibodies appear relatively early
in the immune response, and in fact IgG1 and IgG3 are often the
only IgG subclasses detected in a response (37, 38). This could
result from early antigen clearance preventing the appearance of
IgG2 and IgG4 antibodies. It could also reflect delays in down-
stream class switching as a result of the prevailing cytokine milieu.
T cell cytokines are often said to drive class switching to IgG1 and
IgG3 (39). Alternatively, they could be said to delay class switching
to IgG2 and IgG4, by their promotion of the IgG1 response.
IgG2 antibodies are the second most abundant serum antibod-
ies and the IgG2 gene is positioned immediately downstream of
IgG1. IgG2 antibodies are seen at concentrations that are compa-
rable to IgG1 antibodies, and that are much higher than the typical
serum concentrations of IgG3 and IgG4. In contrast to IgG1 anti-
bodies, IgG2 antibodies fix complement very poorly (40, 41) and
interact very weakly with FcγR (27). In our sequence study, IgG2
antibodies carried a higher mean number of mutations (22.0)
than IgG1 antibodies (21.0) (11). It is difficult to believe that this
higher level of mean mutations would lead to biologically sig-
nificant differences in mean antibody affinity, but certainly IgG2
antibodies must share high affinity with IgG1 antibodies. All these
features of the humoral response require explanation. In particu-
lar, any model of IgG subclass function must explain how IgG1 and
IgG2 antibodies, the two most abundant antibody isotypes, work
together to deliver protective immunity despite their diametrically
opposed properties.
We hypothesize that IgG2-committed cells emerge from the ger-
minal center reaction, on average, shortly after the development
of the IgG1 response. We further hypothesize that IgG2 func-
tions as an anti-inflammatory “partner” to more inflammatory
IgG1 antibodies, “dampening down” the inflammatory response
by its competition with the IgG1 isotype (Figure 2). Working
together, IgG1 and IgG2 antibodies could provide a spectrum of
activity, from the highly inflammatory “pure IgG1 response,” to
the “pure IgG2 response” that results in immune complexes that
cannot interact with FcγR-bearing cells or with molecules of the
complement system.
Mutation data suggests that IgG1 and IgG2 antibodies have
similar affinities. If this is the case, they will compete on a level
playing field, where antibody concentrations prevail. We propose
that the relative concentrations of IgG1 and IgG2 are the result of
the balance of cytokines that either promote or delay switching to
IgG2. These proportions will be seen in the immune complexes
that form during the response, and the outcome of varying pro-
portions of IgG1 and IgG2 antibodies will be immune complexes
having varying avidity for complement and for FcγR. IgG2 can
therefore be conceptualized as an anti-inflammatory brake on the
inflammatory actions of IgG1. In certain circumstances, switching
may occur quickly, leading to a response that is dominated by IgG2.
This could help explain reports that IgG2 dominates the antibody
FIGURE 2 | Immune complex formation over the course of a prolonged
immune response. The likely complement-fixing and FcγR-binding abilities
of immune complexes formed by antibodies of mixed isotypes are
indicated.
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response to carbohydrates response (42). In fact similar concen-
trations of IgG1 and IgG2 antibodies have often been reported in
response to carbohydrate antigens (43–45), and IgG2 antibodies
are also a conspicuous part of the response to many protein anti-
gens (46). It is clear that the chemistry of carbohydrate antigens
cannot explain the IgG2 response.
The human IgG4 response is often described as an anti-
inflammatory blocking response (47), but the apparent functions
of these antibodies have been difficult to reconcile with their
very low concentrations. We believe that their mode of action is
revealed by the levels of mutations that are seen in IgG4-associated
VDJ sequences. IgG4 is the most distal of the IgG subclass genes
within the heavy chain constant region locus. In our sequence
study, IgG4 antibodies carried the highest mean number of VDJ
mutations of the IgG subclasses (mean: 27.1), and no unmutated
IgG4-associated VDJ sequences were seen (11). This suggests to
us that IgG4-committed cells are (typically) the last cell type to
emerge from the germinal center reaction. They are therefore likely
to be the highest affinity antibodies. This is indirectly supported
by the circumstances in which IgG4 antibodies are conspicuous.
Serum IgG4 concentrations are elevated in chronic helminth and
other parasite infections (47). Serum IgG4 concentrations also rise
during allergy desensitization therapy, after repeated exposure to
low doses of allergen (47). They have also been reported in the
convalescent phase of the anti-viral response (35).
IgG4 antibodies do not fix complement and bind very poorly
to activating FcγR (27), but they bind to the inhibitory FcγRIIB
with an affinity that is higher than that of the other three IgG
isotypes (27). Critical to the blocking activity of IgG4, inhibition
is only mediated via the FcγRIIB receptor when immune com-
plexes co-engage FcγRIIB and other activating FcRs (48). Despite
high concentrations of specific antibodies of other isotypes, IgG4
should therefore block FcγR-mediated processes if it is present as
a modest proportion of all antibodies in an immune complex. The
high affinity of IgG4 should provide it with a competitive advan-
tage, ensuring its participation in immune complex formation,
and therefore allowing it to successfully act through FcγRIIB.
The ability of IgG4 antibodies to outcompete other isotypes
may also be facilitated by the phenomenon of Fab arm exchange.
In reducing conditions, IgG4 antibodies have the unique abil-
ity to dissociate into monovalent heavy/light chain pairs, and to
re-associate again as bivalent antibodies (49, 50). This Fab arm
exchange leads frequently to the formation of bi-specific antibod-
ies. It has been suggested that this would, in practice, lead IgG4
antibodies to be functionally monovalent, as Fab arm exchange
would be unlikely between antibodies of related specificities (49).
We believe an alternative explanation of the consequences of Fab
arm exchange could be the formation of blocking antibodies that
bind with very high avidity because of their bi-specific nature.
Bivalency gives power to the IgG molecule. It most obviously
allows a single antibody molecule to aggregate two antigen mol-
ecules, but it also allows high avidity binding to suitably spaced,
repeated epitopes on the surface of a complex antigen. An addi-
tional outcome of bivalency has also been identified. It was first
proposed on theoretical grounds that very weak binding of one
arm of a bivalent antibody molecule to a “non-target” epitope
could substantially improve the avidity of binding of the antibody
to its target epitope, and that the probability of such bi-specific
interactions was reasonably high (51). Recently, such bi-specific
heteroligation was shown to facilitate antibody binding to HIV-
gp140 (52). For a number of antibodies, high affinity interactions
between gp140 and one antigen-binding site were supported by
low affinity binding of the second antibody arm to completely
different epitopes (52).
Fab arm exchange by IgG4 antibodies could improve the like-
lihood of heteroligation, if exchange occurs between antibodies
of related specificities. This would be likely in two situations.
IgG4 antibodies are undetectable in response to many antigens,
and individuals with very low serum IgG4 concentrations are
likely to have a limited IgG4 repertoire. In such circumstances,
Fab arm exchange between antibodies targeting associated epi-
topes or related antigens would be more likely. In individuals
with higher IgG4 concentrations, Fab arm exchange could also
take place between antibodies of related specificities through their
co-localization at sites of inflammation. At such sites, appropri-
ate redox conditions of even a transient nature could lead Fab
arm exchange to “lock together” Fab arms of associated specifici-
ties. This would function to increase IgG4 binding avidity, giving
bi-specific IgG4 antibodies the ability to outcompete the more
inflammatory isotypes, late in a response.
In addition to its IgG1-blocking activity, it is clear that IgG4 can
block IgE-mediated immune function. The IgE and IgG4 isotypes
are strongly linked with one another in the literature, and in fact
IgE antibodies are often said to arise by class switching of IgG4+ B
cells (53, 54). The mutational characteristics that we have reported
clearly demonstrate that this is not always so, for both the number
and patterns of mutations we have seen differ between IgE and
IgG4 (11). However it is possible that IgG4 antibodies could be
related to high affinity IgE, if such IgE antibodies arise late in a
response. Clarification of this question, and determination of the
circumstances in which such high affinity IgE might be produced
by the human immune system will be necessary before late-arising
IgE can be incorporated into the model.
The temporal model, as presented here, outlines sequential class
switching during a first, persisting exposure to antigen. The nature
of isotype expression in a recall response will clearly depend upon
the tendency of class-switched cells to differentiate into memory
cells during the primary response. Though IgM memory cells are
now known to be an important part of the memory compart-
ment (55, 56), there is some evidence from the early literature
that IgG1 dominates the switched memory compartment. Stud-
ies of the recall response after re-challenge with keyhole limpet
hemocyanin (KLH) showed little or no increase in peak concen-
trations of KLH-specific IgG2 and IgG3 antibodies, but a marked
increase in circulating IgG1 anti-KLH antibodies (57). IgG4 anti-
bodies were only seen upon re-challenge. The high affinity of IgG1
and its inflammatory functions make it the ideal isotype for IgG
memory, and the logic of the Temporal Model suggests that mem-
ory cells of the other IgG isotypes could be either unhelpful or
counterproductive.
The contributions that memory cells make to antibody isotype
production in a recall response will depend upon whether mem-
ory cells re-enter germinal centers or immediately differentiate
into plasmablasts and plasma cells. Studies in the mouse sug-
gest that in a recall response, mouse IgG+ memory cells (55) and
IgE+ memory cells (8) rapidly give rise to plasma cells, but IgM+
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memory cells re-enter the germinal center reaction (55). If human
and mouse cells are governed by similar processes, it may therefore
be that events within the human germinal center during a recall
response proceed as we have outlined for earlier events. In other
words, reactivated IgM memory cells within the germinal cen-
ters would give rise to new IgE-switched and IgG-switched cells
through a programed process of sequential switching.
Mechanisms that could underlie the temporal emergence of
different IgG subclasses from the GC reaction will need to be
explored, and one possibility lies in the recently reported com-
petitive feedback between soluble antibody from plasma cells
and the GC B cells (58). Soluble antibody, produced by cells
that have previously emerged and differentiated, competes with
GC B cells for binding to FDC-associated antigen. This com-
petition promotes survival of GC B cells with higher affinity
than the soluble antibody, while B cells of lesser affinity die by
neglect. The Temporal Model suggests that as class switching
proceeds, antibodies expressing subclasses from the more dis-
tally positioned IgG genes are likely to be of higher affinity. At
a particular point in the response, higher affinity antibodies that
express downstream IgG genes would outcompete soluble anti-
body of earlier subclasses, while promoting the destruction of B
cells expressing earlier subclasses that carry fewer mutations and
are of lower affinity. Feedback competition may therefore promote
the temporal emergence of the subclasses in their genomic order.
Many studies give credence to the Temporal Model, but cer-
tainly this is not true of all studies. Discordant observations
could be the result of pathogen-directed perturbations of nor-
mal immune function, for the temporal progression of isotype
switching would be as susceptible as other aspects of immune
function to subversion by bacterial and viral virulence factors (59).
Discordant observations are particularly seen in some early stud-
ies of antibody isotypes, but these reports might be explained by
the cross-reactivity of many early “isotype-specific” reagents (60).
Others might now be explained by phenomena such as Fc–Fc bind-
ing of IgG4 antibodies that were unknown until recently (50). But
the resolution of the mystery of antibody function cannot come
from studies of the past. It is our hope that this description of the
Temporal Model will encourage the question of antibody isotype
function to be revived. Having received so little attention over the
last two decades, it is now time for the power of high throughput
sequencing to be harnessed, to confirm the relationship between
the levels of mutation and antibody isotypes in individuals of dif-
ferent ethnicities and states of health, and to properly address the
clonal relationships between B cells producing antibodies of dif-
ferent isotypes. It may then be that the timing of class switching,
the passage of different cell populations between anatomical com-
partments within the lymph node, the emergence of cells from
the germinal center reaction, and the overall functions of human
isotypes can finally be determined with certainty.
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